Adaptive Biotechnologies understands that each patient's situation is unique. We are committed to providing guidance and support during each step of the insurance process.
That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.
Insurance questions? Cost concerns? LET US POINT THE WAY. Count on our dedicated Case Managers for help with your insurance issues.
Our Case Managers are readily available to answer your insurance questions.